Publisher: Icon Group International, Inc.
Category: Prescription Drugs

Prescription Drugs market research reports by Icon Group International, Inc.

(297 reports matching your criteria)
    • The 2025-2030 World Outlook for Opioids

      The 2025-2030 World Outlook for Opioids This study covers the world outlook for opioids across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent s ... Read More

    • The 2025-2030 World Outlook for Anti-Malarial Drugs

      The 2025-2030 World Outlook for Anti-Malarial Drugs This study covers the world outlook for anti-malarial drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs

      The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs This study covers the world outlook for antiemetic chemotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Influenza Medications

      The 2025-2030 World Outlook for Influenza Medications This study covers the world outlook for influenza medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Contraceptive Drugs

      The 2025-2030 World Outlook for Contraceptive Drugs This study covers the world outlook for contraceptive drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Contraceptive Human Reproductive Technologies

      The 2025-2030 World Outlook for Contraceptive Human Reproductive Technologies This study covers the world outlook for contraceptive human reproductive technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2025-2030 World Outlook for Contraceptive Products

      The 2025-2030 World Outlook for Contraceptive Products This study covers the world outlook for contraceptive products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Infertility Drugs

      The 2025-2030 World Outlook for Infertility Drugs This study covers the world outlook for infertility drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Glaucoma Pharmaceuticals

      The 2025-2030 World Outlook for Glaucoma Pharmaceuticals This study covers the world outlook for glaucoma pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Emergency Contraceptive Pills

      The 2025-2030 World Outlook for Emergency Contraceptive Pills This study covers the world outlook for emergency contraceptive pills across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Healthcare Supply Chain Management Software

      The 2025-2030 World Outlook for Healthcare Supply Chain Management Software This study covers the world outlook for healthcare supply chain management software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for E-Prescription Systems Solutions

      The 2025-2030 World Outlook for E-Prescription Systems Solutions This study covers the world outlook for e-prescription systems solutions across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Epilepsy Treatments

      The 2025-2030 World Outlook for Epilepsy Treatments This study covers the world outlook for epilepsy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for E-Prescription

      The 2025-2030 World Outlook for E-Prescription This study covers the world outlook for e-prescription across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More

    • The 2025-2030 World Outlook for E-Prescription Systems

      The 2025-2030 World Outlook for E-Prescription Systems This study covers the world outlook for e-prescription systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Pharma Contract Sales

      The 2025-2030 World Outlook for Pharma Contract Sales This study covers the world outlook for pharma contract sales across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics

      The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics This study covers the world outlook for cervical cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for HIV-AIDS Drugs

      The 2025-2030 World Outlook for HIV-AIDS Drugs This study covers the world outlook for HIV-AIDS drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More

    • The 2025-2030 World Outlook for Farm Animal Drugs

      The 2025-2030 World Outlook for Farm Animal Drugs This study covers the world outlook for farm animal drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Herpes Simplex Virus Treatments

      The 2025-2030 World Outlook for Herpes Simplex Virus Treatments This study covers the world outlook for herpes simplex virus treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Wholesale and Distribution of Branded Drug Pharmaceuticals

      The 2025-2030 World Outlook for Wholesale and Distribution of Branded Drug Pharmaceuticals This study covers the world outlook for wholesale and distribution of branded drug pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potentia ... Read More

    • The 2025-2030 World Outlook for Metronidazol for Clostridium Difficile Treatments

      The 2025-2030 World Outlook for Metronidazol for Clostridium Difficile Treatments This study covers the world outlook for metronidazol for clostridium Difficile treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More

    • The 2025-2030 World Outlook for Dermatitis Drugs

      The 2025-2030 World Outlook for Dermatitis Drugs This study covers the world outlook for dermatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Subcutaneous Immunoglobin

      The 2025-2030 World Outlook for Subcutaneous Immunoglobin This study covers the world outlook for subcutaneous immunoglobin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Hepatitis C Treatments

      The 2025-2030 World Outlook for Hepatitis C Treatments This study covers the world outlook for hepatitis c treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings